Insight Molecular Diagnostics (IMDX) Amortizatization of Intangibles (2016 - 2025)
Insight Molecular Diagnostics' Amortizatization of Intangibles history spans 6 years, with the latest figure at $7000.0 for Q1 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 68.18% to $7000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $7000.0, a 92.05% decrease, with the full-year FY2025 number at $7000.0, down 92.05% from a year prior.
- Amortizatization of Intangibles hit $7000.0 in Q1 2025 for Insight Molecular Diagnostics, down from $22000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IMDX hit a ceiling of $1.1 million in Q2 2021 and a floor of $7000.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $424470.6 across 5 years, with a median of $22000.0 in 2023.
- Biggest five-year swings in Amortizatization of Intangibles: surged 4781.82% in 2021 and later tumbled 97.75% in 2023.
- Tracing IMDX's Amortizatization of Intangibles over 5 years: stood at $990000.0 in 2021, then decreased by 20.0% to $792000.0 in 2022, then tumbled by 97.22% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then crashed by 68.18% to $7000.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for IMDX at $7000.0 in Q1 2025, $22000.0 in Q4 2024, and $22000.0 in Q3 2024.